Teva announces changes to executive management team

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today announced changes to its leadership team. sven dethlefs, executive vice president, north america commercial, will leave teva on november 17, 2023, and christine (chris) fox, who most recently served as global president, gene therapies at novartis will be the new head of teva's u.s. commercial business. “on behalf of the teva board of directors and our executive management team,.
TEVA Ratings Summary
TEVA Quant Ranking